RB Goldberg, JR Guyton, T Mazzone, RS … - Mayo Clinic Proceedings, 2006 - mayoclinicproceedings.com RESULTS: A total of 1229 patients participated in the study. Significantly
greater mean reductions were found in LDL-C levels with ezetimibe/simvastatin,
10/20 mg/d (-53.6%; 95% confidence interval [CI], -55.4% to -51.8%), than ... Cited by 51 - Related articles - BL Direct - All 10 versions
HN Ginsberg, YL Zhang, A Hernandez-Ono - Obesity, 2006 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications
AZ index; Browse by subject; The Obesity Society. My account; ... Cited by 30 - Related articles - BL Direct - All 4 versions
BK Irons, RS Greene, TA Mazzolini, KL … - Pharmacotherapy, 2006 - PPI Brian K. Irons, Pharm.D., Ronald Shane Greene, Pharm.D., Timothy A. Mazzolini,
Pharm.D., Krystal L. Edwards, Pharm.D., and Rebecca B. Sleeper, Pharm.D. ...
Clinical data suggest that thiazolidinediones—specifically, rosiglitazone ... Cited by 27 - Related articles - BL Direct - All 3 versions
M Shaheen, D Echeverry, MG Oblad, MI … - Diabetes research and clinical practice, 2007 - Elsevier Studies have shown that hepatitis C (HCV) is associated with type 2 diabetes
mellitus (DM2) possibly due to insulin resistance and inflammation. Metabolic
syndrome is a risk factor for DM2. Our objectives were to assess the ... Cited by 22 - Related articles - All 16 versions
- ►ahajournals.org HS Markus, R Labrum, S Bevan, M Reindl, G … - Stroke, 2006 - Am Heart Assoc From the Centre for Clinical Neuroscience (HSM, RL, SB) and John Parker Chair of
Vascular Biology (QX), Department of Cardiac and Vascular Sciences, St George's
University of London, UK; the Department of Neurology (MR, SK, JW), ... Cited by 25 - Related articles - All 11 versions
S Engebretson, R Chertog, A Nichols, J Hey- … - Journal of clinical periodontology, 2007 - periomedicine.it Abstract Objectives: Studies suggest that elevated circulating tumour necrosis
factor-a (TNF-a) may contribute to insulin resistance in patients with type 2
diabetes. The source of plasma TNF has been thought to be adipocytes ... Cited by 20 - Related articles - View as HTML - BL Direct - All 13 versions
L Weiping, C Qingfeng, M Shikun, L Xiurong, … - Endocrine, 2006 - Springer Received September 29, 2006; Revised October 26, 2006; Accepted November 27,
2006. Author to whom all correspondence and reprint requests should be
addressed: Li Qifu, MD, PhD, Department of Endocrinology, the First ... Cited by 20 - Related articles - BL Direct - All 3 versions
- ►physiology.org [PDF] LG Sanchez-Lozada, E Tapia, P Bautista- … - American Journal of Physiology- Renal Physiology, 2008 - Am Physiological Soc Page 1. 1 Effects of febuxostat on metabolic and renal alterations in rats
with fructose-induced metabolic syndrome Laura G. Sánchez ... Cited by 18 - Related articles - BL Direct - All 3 versions
CV Rizos, EN Liberopoulos, DP Mikhailidis, … - Expert Opin. Pharmacother., 2008 - informahealthcare.com Background: Insulin resistance and hyperglycemia characterize type 2 diabetes
mellitus. Type 2 diabetes mellitus is usually accompanied by concomitant
disorders, such as dyslipidemia, hypertension and atherosclerosis. ... Cited by 18 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org ML Jehn, E Guallar, JM Clark, D Couper, BB … - American journal of epidemiology, 2007 - Oxford Univ Press The authors performed a case-cohort study nested within the Atherosclerosis Risk
in Communities (ARIC) Study to determine the association between plasma ferritin
level and risk of type 2 diabetes mellitus. Persons with incident cases of ... Cited by 17 - Related articles - BL Direct - All 6 versions
